vs
BXP, Inc.（BXP）与Insulet Corporation（PODD）财务数据对比。点击上方公司名可切换其他公司
BXP, Inc.的季度营收约是Insulet Corporation的1.1倍（$872.1M vs $783.7M），BXP, Inc.净利率更高（15.3% vs 13.0%，领先2.3%），Insulet Corporation同比增速更快（31.2% vs 0.8%），过去两年Insulet Corporation的营收复合增速更高（33.2% vs 1.3%）
BXP是美国头部商业地产投资信托企业，核心业务为持有、运营及开发A级高端写字楼资产，项目覆盖纽约、波士顿、旧金山等美国核心都市圈，服务企业、科技、专业服务等领域的多元租户。
Insulet Corporation是深耕糖尿病治疗领域的医疗器械企业，核心产品为胰岛素泵，通过持续皮下输注胰岛素的疗法为患者给药。其产品通常由泵主体、一次性胰岛素储药仓，以及包含皮下植入套管和连接管路的一次性输注套件构成，满足不同患者的治疗需求。
BXP vs PODD — 直观对比
营收规模更大
BXP
是对方的1.1倍
$783.7M
营收增速更快
PODD
高出30.4%
0.8%
净利率更高
BXP
高出2.3%
13.0%
两年增速更快
PODD
近两年复合增速
1.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $872.1M | $783.7M |
| 净利润 | $133.0M | $101.6M |
| 毛利率 | — | 72.6% |
| 营业利润率 | — | 18.7% |
| 净利率 | 15.3% | 13.0% |
| 营收同比 | 0.8% | 31.2% |
| 净利润同比 | 53.0% | 0.9% |
| 每股收益（稀释后） | $1.69 | $1.42 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BXPPODD
| Q1 26 | $872.1M | — | ||
| Q4 25 | $877.1M | $783.7M | ||
| Q3 25 | $871.5M | $706.3M | ||
| Q2 25 | $868.5M | $649.1M | ||
| Q1 25 | $865.2M | $569.0M | ||
| Q4 24 | $858.6M | $597.5M | ||
| Q3 24 | $859.2M | $543.9M | ||
| Q2 24 | $850.5M | $488.5M |
净利润BXPPODD
| Q1 26 | $133.0M | — | ||
| Q4 25 | $248.4M | $101.6M | ||
| Q3 25 | $-121.7M | $87.6M | ||
| Q2 25 | $89.0M | $22.5M | ||
| Q1 25 | $61.2M | $35.4M | ||
| Q4 24 | $-228.9M | $100.7M | ||
| Q3 24 | $83.6M | $77.5M | ||
| Q2 24 | $79.6M | $188.6M |
毛利率BXPPODD
| Q1 26 | — | — | ||
| Q4 25 | 58.8% | 72.6% | ||
| Q3 25 | 59.3% | 72.2% | ||
| Q2 25 | 59.2% | 69.7% | ||
| Q1 25 | 59.2% | 71.9% | ||
| Q4 24 | 59.7% | 72.1% | ||
| Q3 24 | 59.5% | 69.3% | ||
| Q2 24 | 59.8% | 67.7% |
营业利润率BXPPODD
| Q1 26 | — | — | ||
| Q4 25 | — | 18.7% | ||
| Q3 25 | — | 16.7% | ||
| Q2 25 | — | 18.7% | ||
| Q1 25 | — | 15.6% | ||
| Q4 24 | — | 18.3% | ||
| Q3 24 | — | 16.2% | ||
| Q2 24 | — | 11.2% |
净利率BXPPODD
| Q1 26 | 15.3% | — | ||
| Q4 25 | 28.3% | 13.0% | ||
| Q3 25 | -14.0% | 12.4% | ||
| Q2 25 | 10.2% | 3.5% | ||
| Q1 25 | 7.1% | 6.2% | ||
| Q4 24 | -26.7% | 16.9% | ||
| Q3 24 | 9.7% | 14.2% | ||
| Q2 24 | 9.4% | 38.6% |
每股收益（稀释后）BXPPODD
| Q1 26 | $1.69 | — | ||
| Q4 25 | $1.56 | $1.42 | ||
| Q3 25 | $-0.77 | $1.24 | ||
| Q2 25 | $0.56 | $0.32 | ||
| Q1 25 | $0.39 | $0.50 | ||
| Q4 24 | $-1.46 | $1.38 | ||
| Q3 24 | $0.53 | $1.08 | ||
| Q2 24 | $0.51 | $2.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $512.8M | — |
| 总债务越低越好 | — | $930.8M |
| 股东权益账面价值 | $7.7B | $1.5B |
| 总资产 | $25.1B | $3.2B |
| 负债/权益比越低杠杆越低 | — | 0.61× |
8季度趋势，按日历期对齐
现金及短期投资BXPPODD
| Q1 26 | $512.8M | — | ||
| Q4 25 | $1.5B | — | ||
| Q3 25 | $861.1M | — | ||
| Q2 25 | $447.0M | — | ||
| Q1 25 | $398.1M | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $685.4M | — |
总债务BXPPODD
| Q1 26 | — | — | ||
| Q4 25 | — | $930.8M | ||
| Q3 25 | — | $934.9M | ||
| Q2 25 | — | $939.0M | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B |
股东权益BXPPODD
| Q1 26 | $7.7B | — | ||
| Q4 25 | $5.1B | $1.5B | ||
| Q3 25 | $5.0B | $1.4B | ||
| Q2 25 | $5.3B | $1.5B | ||
| Q1 25 | $5.3B | $1.3B | ||
| Q4 24 | $5.4B | $1.2B | ||
| Q3 24 | $5.8B | $1.1B | ||
| Q2 24 | $5.8B | $998.4M |
总资产BXPPODD
| Q1 26 | $25.1B | — | ||
| Q4 25 | $26.2B | $3.2B | ||
| Q3 25 | $26.0B | $3.0B | ||
| Q2 25 | $25.6B | $3.5B | ||
| Q1 25 | $25.4B | $3.5B | ||
| Q4 24 | $26.1B | $3.1B | ||
| Q3 24 | $26.4B | $3.0B | ||
| Q2 24 | $25.5B | $2.9B |
负债/权益比BXPPODD
| Q1 26 | — | — | ||
| Q4 25 | — | 0.61× | ||
| Q3 25 | — | 0.68× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | 1.07× | ||
| Q3 24 | — | 1.21× | ||
| Q2 24 | — | 1.36× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $183.3M |
| 自由现金流经营现金流 - 资本支出 | — | $48.2M |
| 自由现金流率自由现金流/营收 | — | 6.2% |
| 资本支出强度资本支出/营收 | 1.5% | 17.2% |
| 现金转化率经营现金流/净利润 | — | 1.80× |
| 过去12个月自由现金流最近4个季度 | — | $377.7M |
8季度趋势，按日历期对齐
经营现金流BXPPODD
| Q1 26 | — | — | ||
| Q4 25 | $407.8M | $183.3M | ||
| Q3 25 | $274.2M | $125.7M | ||
| Q2 25 | $353.1M | $196.5M | ||
| Q1 25 | $210.0M | $63.8M | ||
| Q4 24 | $383.7M | $147.7M | ||
| Q3 24 | $286.1M | $98.5M | ||
| Q2 24 | $367.1M | $96.5M |
自由现金流BXPPODD
| Q1 26 | — | — | ||
| Q4 25 | $362.7M | $48.2M | ||
| Q3 25 | $231.6M | $100.1M | ||
| Q2 25 | $281.5M | $177.9M | ||
| Q1 25 | $152.6M | $51.5M | ||
| Q4 24 | $312.5M | $94.1M | ||
| Q3 24 | $234.5M | $71.8M | ||
| Q2 24 | $332.4M | $74.0M |
自由现金流率BXPPODD
| Q1 26 | — | — | ||
| Q4 25 | 41.4% | 6.2% | ||
| Q3 25 | 26.6% | 14.2% | ||
| Q2 25 | 32.4% | 27.4% | ||
| Q1 25 | 17.6% | 9.1% | ||
| Q4 24 | 36.4% | 15.7% | ||
| Q3 24 | 27.3% | 13.2% | ||
| Q2 24 | 39.1% | 15.1% |
资本支出强度BXPPODD
| Q1 26 | 1.5% | — | ||
| Q4 25 | 5.1% | 17.2% | ||
| Q3 25 | 4.9% | 3.6% | ||
| Q2 25 | 8.2% | 2.9% | ||
| Q1 25 | 6.6% | 2.2% | ||
| Q4 24 | 8.3% | 9.0% | ||
| Q3 24 | 6.0% | 4.9% | ||
| Q2 24 | 4.1% | 4.6% |
现金转化率BXPPODD
| Q1 26 | — | — | ||
| Q4 25 | 1.64× | 1.80× | ||
| Q3 25 | — | 1.43× | ||
| Q2 25 | 3.97× | 8.73× | ||
| Q1 25 | 3.43× | 1.80× | ||
| Q4 24 | — | 1.47× | ||
| Q3 24 | 3.42× | 1.27× | ||
| Q2 24 | 4.61× | 0.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BXP
| Lease | $818.2M | 94% |
| Parking and other | $30.8M | 4% |
| Development and management services | $9.2M | 1% |
PODD
| U.S.Omnipod | $567.8M | 72% |
| International Omnipod | $214.0M | 27% |
| Drug Delivery | $1.9M | 0% |
